with Klinefelter Syndrome/XXY chromosomes are in this position but nonetheless usually cannot compete while utilizing testosterone because of their medical situation. In the Semenya case the fact that they found high testosterone levels and were going back and forth on her gender verification affected her mental health. By contradicting her sex they were violating laws by international and national genetic privacy laws. Gender verification impacts numerous dimensions of athletes' lives, including unfair disqualification in sporting events, identity crisis and confusion, social isolation, depression, and suicide. Transgender athletes Transgender athletes who wish to compete in the female category are allowed to do so if their testosterone levels are in accordance with the required levels. However, the IOC stated that requiring surgical anatomical changes as a requirement for participation may be considered a violation of human rights. Athletics may for some transgender people engage them within greater society in affirming ways. However, others opposed the participation of transgender athletes on women's teams state that the argument is unsound. Athletes who have faced opposition include Mianne Bagger, Martine Delaney (who participated in "Soccer Tasmanian's women's league") and Lana Lawless. Hormone Testing in Post Secondary Education In 2011, the NCAA made a statement of inclusivity for Transgender athletes competing in college athletics. Through this statement, the NCAA was able to structure an implementation plan for transgender athletes to participate in college sports, and some policies that would ensure an equitable opportunity for every athlete. The following are the specific guidelines for transgender athletes incorporated into the NCAA in 2011:1. A trans male (FTM) student-athlete who has received a medical exception for treatment with testosterone for diagnosed Gender Identity Disorder or gender dysphoria and/or Transsexualism, for purposes of NCAA competition may compete on a men’s team, but is no longer eligible to compete on a women’s team without changing that team status to a mixed team. 2. A trans female (MTF) student-athlete being treated with testosterone suppression medication for Gender Identity Disorder or gender dysphoria and/or Transsexualism, for the purposes of NCAA competition may continue to compete on a men’s team but may not compete on a women’s team without changing it to a mixed team status until completing one calendar year of testosterone suppression treatment.In 2021, however, the NCAA adjusted the previous policy of requiring one calendar year of testosterone suppressing therapy for transgender female athletes. Instead, now there is more frequent testosterone testing.